Proxalutamide
Showing 1 - 9 of 9
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Manaus (Proxalutamide, Placebo)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Proxalutamide
- Placebo
-
Manaus, Amazonas, BrazilSamel Hospital
Feb 17, 2022
Covid19, SARS-CoV Infection Trial in Brasilia (Proxalutamide, Standard of Care)
Withdrawn
- Covid19
- SARS-CoV Infection
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Feb 17, 2022
Efficacy and Safety Trial in United States (Proxalutamide (GT0918), Placebo)
Completed
- Efficacy and Safety
- Proxalutamide (GT0918)
- Placebo
-
Phoenix, Arizona
- +7 more
Jun 20, 2022
Neoadjuvant Therapy \High Risk Prostate Cancer Trial in Nanjing (, Proxalutamide)
Recruiting
- Neoadjuvant Therapy \High Risk Prostate Cancer
- placebo
- Proxalutamide
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Oct 12, 2021
COVID-19 Trial in Brasília (Proxalutamide, Placebo)
Completed
- COVID-19
- Proxalutamide
- Placebo
-
Brasília, DF, BrazilCorpometria Institute
Nov 17, 2021
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Brazil (Proxalutamide, Placebo)
Completed
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Proxalutamide
- Placebo
-
Itacoatiara, Amazonas, Brazil
- +7 more
Jun 22, 2021
COVID-19, SARS-CoV2, Androgenetic Alopecia Trial in Brasilia (Proxalutamide, Standard of Care)
Completed
- COVID-19
- +5 more
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Dec 8, 2021
Metastatic Castrate Resistant Prostate Cancer (mCRPC) Trial in United States (GT0918)
Completed
- Metastatic Castrate Resistant Prostate Cancer (mCRPC)
-
Towson, Maryland
- +5 more
Mar 13, 2020
COVID-19 Trial in São Paulo (GT0918 tablets or )
Recruiting
- COVID-19
- GT0918 tablets or placebo
-
São Paulo, SP, BrazilHospital Santa Paula
Oct 18, 2021